Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
A Time of Careful Eating: Individual Tests in Nourishment - 2What to know about the "wild, wild West" of viral peptide claims
- 3Vaccine exemptions for religious or personal beliefs are rising across the U.S.
- 4UK consumer confidence plunges amid escalating Iran conflict
- 5UN torture cm'tee report flags Israel for allegedly mistreating journalists, detainees, ex-MAG
- Manual for Individual accounting Rudiments for Fledglings
- Viable Correspondence: Building Solid Connections
- Ski Resorts Universally: A Colder time of year Wonderland Guide
- Step by step instructions to Contrast Lab Jewels and Regular Ones
- Rick Steves Recommends This German Town's Castle Hotel With Rhine River Views
- Looter indicted after pretending to be emergency worker at Dimona rocket crash site
- Which sandwich do you find totally delectable? !
- Cameroon says Russia has confirmed 16 Cameroonian soldiers died in Ukraine
- Pick Your Favored kind of sandwich
